ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 2616

Ischemia-Modified Albumin : A Novel Marker of Vascular Involvement in Behcet’s Disease ?

Erhan Capkin1, Murat Karkucak2, Mehmet Kola3, Adem Karaca2, süleyman Caner Karahan4, Aysegul Sumer4, Arzu Aydin Capkin5, Ferhat Gokmen2 and Refik Ali Sari6, 1rheumatolgy, trabzon, Turkey, 2rheumatology, trabzon, Turkey, 3oftalmology, trabzon, Turkey, 4biochemistry, trabzon, Turkey, 5dermatology, trabzon, Turkey, 6immunology and allergy, trabzon, Turkey

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Behcet's syndrome, stress and vasculitis

  • Tweet
  • Email
  • Print
Session Information

Session Title: Vasculitis III

Session Type: Abstract Submissions (ACR)

Background/Purpose: The etiology and pathogenesis of Behçet’s disease (BD) are not yet well understood, but immunoregulatory abnormalities have been proposed as pathogenic mechanisms. Ischemia-modified albumin (IMA) is increased in diseases associated with oxidative stress, which plays an important role in the development of Behçet’s disease.To investigate oxidative status and IMA levels in patients with Behçet’s disease and their association with clinical and laboratory parameters

Methods:

Thirty-five patients with Behçet’s disease and 31 healthy controls matched for age and gender were enrolled. Patients’ clinical and demographic characteristics were recorded. Serum IMA, malondialdehyde (MDA), total antioxidative status (TAS), total oxidative status (TOS) and oxidative stress index (OSI) levels were then evaluated.

Results:

Serum IMA, MDA, TOS and OSI levels were significantly higher in patients with Behçet’s disease than in the healthy control group. Serum TAS was significantly lower in patients with Behçet’s disease than in the healthy controls. There was a statistically significant positive correlation between IMA levels and MDA, TOS, erythrocyte sedimentation rate and C-reactive protein levels. IMA levels were statistically significantly higher in patients with vascular involvement (p=0.016).

Conclusion: Our results demonstrate increased oxidative stress and decreased antioxidant capacity in patients with Behçet’s disease. IMA levels were higher in patients with Behçet’s disease than in healthy controls. IMA may be produced through an adaptive response to chronic hypoxia and oxidative stress, which may play a role in the systemic inflammation seen in Behçet’s disease. IMA can be a useful guiding marker, particularly in patients with vascular involvement.


Disclosure:

E. Capkin,
None;

M. Karkucak,
None;

M. Kola,
None;

A. Karaca,
None;

S. C. Karahan,
None;

A. Sumer,
None;

A. A. Capkin,
None;

F. Gokmen,
None;

R. A. Sari,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ischemia-modified-albumin-a-novel-marker-of-vascular-involvement-in-behcets-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies